Identification of Novel Small-Molecule ASGP-R Ligands

Author(s): Alexander G. Majouga, Yan A. Ivanenkov, Mark S. Veselov, Anton V. Lopuhov, Svetlana V. Maklakova, Elena K. Beloglazkina, Petr V. Binevski, Natalya L. Klyachko, Yuri B. Sandulenko, Natalia Y. Galkina, Victor E. Koteliansky

Journal Name: Current Drug Delivery

Volume 13 , Issue 8 , 2016

Become EABM
Become Reviewer
Call for Editor

Graphical Abstract:


During the past decade asialoglycoprotein receptor (ASGP-R) expressed predominantly by hepatocytes has attracted a considerable attention as a convenient biomolecular trap for targeted drug delivery. Currently, several selective galactose-containing ligands equipped by drug molecules, e.g. known anticancer therapeutics, as well as diagnostic tools are under active preclinical development. In this paper, we have carried out a rational in silico screening among the molecules available in ChemDiv collection and compounds provided by our colleagues to reveal potential ASGP-R binders. Thus, 3D molecular docking approach provided a set of 100 `high score` molecules that was subsequently evaluated in vitro using an advanced Surface Plasmon Resonance (SPR) technique. As a result, dozens of novel small-molecule ASGP-R ligands with high diversity in structure were identified. Several hits showed the binding affinity much more better than that determined for galactose and Nacetylgalactosamine which were used as reference compounds. The disclosed molecules can be reasonably regarded as promising molecular devices for targeted drug delivery to hepatocytes.

Keywords: Asialoglycoprotein receptor (ASGRP-R), drug delivery, docking, in silico, screening.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2016
Published on: 07 November, 2016
Page: [1303 - 1312]
Pages: 10
DOI: 10.2174/1567201813666160719144651
Price: $65

Article Metrics

PDF: 75
PRC: 1